AquaBounty supporters appeal to U.S. President to help remove FDA regulatory bottleneck

A group of 56 scientists, developers and investors that support AquaBounty Technologies and their new animal drug application to the U.S. Food and Drug Administration (FDA) sent a letter to President Obama on September 15, 2012 asking for his help in removing the regulatory bottleneck that is holding up the review process of the AquAdvantage Salmon, the world’s first genetically engineered food animal.

“Mr. President, we are writing today as a group of scientists, developers and investors to follow up and urge the Administration to make the same bold commitment to animal agriculture as it has to plant agriculture. A decision on genetically modified salmon has been pending at FDA for years. We are hoping you would urge the FDA to move forward on this important decision. The inexplicable regulatory bottleneck that has been encountered by the “AquAdvantage” salmon suggests that the FDA’s science-based regulatory review process for the products of animal biotechnology has no predictable timeline and is holding up the development of an industry that promotes economic growth, innovation, competitiveness, and job creation in the United States.”

The full text of the letter and list of signatories can be viewed by clicking here.